DE2215834A1 - - Google Patents
Info
- Publication number
- DE2215834A1 DE2215834A1 DE19722215834 DE2215834A DE2215834A1 DE 2215834 A1 DE2215834 A1 DE 2215834A1 DE 19722215834 DE19722215834 DE 19722215834 DE 2215834 A DE2215834 A DE 2215834A DE 2215834 A1 DE2215834 A1 DE 2215834A1
- Authority
- DE
- Germany
- Prior art keywords
- lower alkanol
- pivaloyloxymethyl
- tablets
- mixed
- isopropanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 10
- 235000019359 magnesium stearate Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 5
- -1 pivaloyloxymethyl Chemical group 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000003115 biocidal effect Effects 0.000 claims description 3
- 229940127022 high-dose drug Drugs 0.000 claims description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims 2
- 239000003826 tablet Substances 0.000 description 30
- 239000000314 lubricant Substances 0.000 description 9
- 239000003814 drug Substances 0.000 description 7
- 239000003979 granulating agent Substances 0.000 description 7
- 229940079593 drug Drugs 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000009481 moist granulation Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000009475 tablet pressing Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13085771A | 1971-04-02 | 1971-04-02 | |
| US23260172A | 1972-03-07 | 1972-03-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2215834A1 true DE2215834A1 (enrdf_load_stackoverflow) | 1972-10-19 |
Family
ID=26828886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19722215834 Pending DE2215834A1 (enrdf_load_stackoverflow) | 1971-04-02 | 1972-03-30 |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE2215834A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2132356B1 (enrdf_load_stackoverflow) |
| GB (1) | GB1359118A (enrdf_load_stackoverflow) |
| NL (1) | NL7204264A (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1413516A (en) * | 1972-10-06 | 1975-11-12 | Leo Pharm Prod Ltd | Crystalline pivaloyloxymethal d - -alpha- aminobenzylpenicillinate |
| FR2282258A1 (fr) * | 1974-08-19 | 1976-03-19 | Merck & Co Inc | Procede de preparation de comprimes a forte teneur en chlorhydrate de d-(-)-alpha-aminobenzylpenicillinate de pivaloyloxymethyle |
-
1972
- 1972-03-29 NL NL7204264A patent/NL7204264A/xx unknown
- 1972-03-29 GB GB1486272A patent/GB1359118A/en not_active Expired
- 1972-03-30 DE DE19722215834 patent/DE2215834A1/de active Pending
- 1972-03-31 FR FR7211565A patent/FR2132356B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR2132356B1 (enrdf_load_stackoverflow) | 1976-05-07 |
| GB1359118A (en) | 1974-07-10 |
| NL7204264A (enrdf_load_stackoverflow) | 1972-10-04 |
| FR2132356A1 (enrdf_load_stackoverflow) | 1972-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2224534C3 (de) | Pharmazeutisches Präparat mit langsamer Wirkstoffabgabe | |
| DE69528204T2 (de) | Tabletten enthaltend Amoxicillin und Clavulanate, die mit einem Polymerüberzug versehen sind | |
| EP0128482B1 (de) | Neue galenische Zubereitungsformen von oralen Antidiabetika und Verfahren zu ihrer Herstellung | |
| DE69820287T2 (de) | Pharmazeutische Zubereitung, die Chlodronat als Wirkstoff und silicifizierte mikrokristalline Cellulose als Exipienten umfasst | |
| DE3811114C2 (de) | Zweischichtige Dosierungsform zur Abgabe eines Wirkstoffs | |
| AT394310B (de) | Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge | |
| DE3441308C2 (de) | Wirkstofffreie oder wirkstoffhaltige matrixbildende Granalien, geeignet zur Herstellung von pharmazeutischen Präparaten mit geregelter beziehungsweise verzögerter Wirkstoffabgabe sowie Verfahren zur Herstellung derselben | |
| DE69322396T2 (de) | Steroide enthaltende pharmazeutische Granulate | |
| DE2855825C2 (de) | Verwendung von Aktivkohleteilchen als Antidot | |
| DE2808514A1 (de) | Nitrofurantoin enthaltende tablette | |
| DE1229248B (de) | Verfahren zur Herstellung von Arzneimitteln in fester Form | |
| DE2907215A1 (de) | Feste depotarzneimittelpraeparate und verfahren zu deren herstellung | |
| DE69814850T2 (de) | Paracetamol enthaltende schlickbare tablette | |
| DE69111574T2 (de) | Polycarbophil-Kalzium enthaltendes Arzneimittel. | |
| DE2200778B2 (de) | Verwendung von hochmolekularem, unlöslichem, quervernetztem Polyvinylpyrrolidon als Sprengmittel in festen Arzneiformen | |
| DE69008107T2 (de) | Zubereitung mit verzögerter Freigabe eines Hydrochlorids eines basischen Arzneistoffs. | |
| DE1492253A1 (de) | Verfahren zur Herstellung von Tabletten mit protrahierter Wirkung | |
| DE1195012B (de) | Verfahren zur Herstellung eines geformten Koerpers zur Abgabe therapeutisch wirksamer Stoffe | |
| DE4414544A1 (de) | Depottablette | |
| DE2251250A1 (de) | Verfahren zur herstellung hochdosierter antibiotica-tabletten | |
| DE2215834A1 (enrdf_load_stackoverflow) | ||
| DE69524226T2 (de) | Verfahren zum herstellen von fusidinsäuretabletten | |
| DE60203997T2 (de) | Nasses granulationsverfahren zur herstellung von pharmazeutischen tabletten mit paroxetinhydrochlorid anhydrat | |
| DE2259646A1 (de) | Hochdosierte tabletten von cephalosporin-derivaten sowie verfahren zu ihrer herstellung | |
| DE68907609T2 (de) | Arzneimittelzusammensetzung. |